Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free
- 31 October 2004
- journal article
- research article
- Published by Elsevier BV in European Journal of Surgical Oncology
- Vol. 30 (8), 851-856
- https://doi.org/10.1016/j.ejso.2004.06.021
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Relapse and Morbidity in Patients Undergoing Sentinel Lymph Node Biopsy Alone or With Axillary Dissection for Breast CancerArchives of Surgery, 2003
- Shoulder–arm morbidity following axillary dissection and sentinel node only biopsy for breast cancerEuropean Journal of Surgical Oncology, 2002
- Sensory morbidity after sentinel lymph node biopsy and axillary dissection: A prospective study of 233 womenAnnals of Surgical Oncology, 2002
- Sentinel lymph node biopsy in malignant melanoma: a series of 100 consecutive patientsBritish Journal of Plastic Surgery, 2000
- Lymphatic mapping with sentinel node biopsy in pediatric patientsJournal of Pediatric Surgery, 2000
- Lymphedema After Sentinel Lymph Node Biopsy for Cutaneous MelanomaArchives of Dermatology, 2000
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992
- Natural history and selective management of in transit melanomaJournal of Surgical Oncology, 1990
- Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patientsCancer, 1983
- Isolated Regional Lymph Node Dissection; Morbidity, Mortality and Economic ConsiderationsAnnals of Surgery, 1981